Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome study. (Q47315054)
Jump to navigation
Jump to search
scientific article published in January 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome study. |
scientific article published in January 2003 |
Statements
Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome study (English)
Huland E
Burger A
Fleischer J
Fornara P
Hatzmann E
Heidenreich A
Heinzer H
Heynemann H
Hoffmann L
Hofmann R
Huland H
Kämpfer I
Kindler M
Kirchner H
Mehlhorn G
Moniak TH
Rebmann U
Roigas J
Schneider TH
Schnorr D
Schmitz HJ
Wenisch R
Varga Z